KJT is expanding its portfolio with the integration of Sparq’s Connection and Prediction capabilities. As a healthcare market research and consulting firm focused on patient- and provider-centered insight, this addition strengthens our ability to support both Real-World Evidence and Commercial initiatives.
By combining human-centered research expertise with responsibly applied AI-supported approaches, we deliver deeper understanding, greater clarity, and more confident decision-making for life sciences organizations.
Expanding Conversational Insight with Connection
Connection leverages AI-supported conversational tools to facilitate natural, guided dialogue with patients and healthcare providers. These conversations are interpreted by KJT researchers within a clinical and therapeutic context to ensure insights remain grounded in real-world healthcare experience.
With Connection, clients can:
- Capture authentic patient and provider voice at scale
- Identify emotional drivers and communication gaps
- Explore sensitive or complex topics in a structured, ethical environment
- Translate qualitative input into clear, actionable insight
This capability supports initiatives ranging from message testing and market exploration to communication improvement and patient experience strategy.
Enhancing Predictive Understanding with Prediction
Prediction extends KJT’s insight ecosystem by using responsibly developed models to simulate and forecast stakeholder behaviors in complex healthcare environments.
With Prediction, organizations can:
- Develop representative digital audience profiles
- Validate assumptions before full-scale research investment
- Run rapid scenario testing
- Explore niche and hard-to-reach populations efficiently
Together, Connection and Prediction enable KJT to provide both deep qualitative understanding and forward-looking insight, supporting smarter strategic planning across the product lifecycle.
A Strategic Step Forward
“This integration reflects our commitment to advancing healthcare insight through the combination of scientific rigor, therapeutic expertise, and responsible innovation,” said Michaela Gascon, President and Chief Executive Officer of KJT.
By embedding these capabilities within its healthcare-focused framework, KJT continues to prioritize responsible AI, therapeutic depth, and real-world applicability — ensuring insights are not only faster, but more meaningful.
